Loading…
Loading…
See price against where its own fundamentals say it should trade. The shaded gap is the discount or premium, across five valuation lenses.
TapClick below to see what's inside, then upgrade to unlock for CRT and 80,000+ other tickers.
See exactly how CRT's revenue becomes profit: a Sankey that traces revenue (and its reported segments) through gross profit, operating expenses, and net profit, with the year-over-year change on every line.
The same diagram the Chart Builder draws, right on the Summary tab. Upgrade to unlock it for CRT and 80,000+ other tickers.
Cross Timbers Royalty Trust functions as an express trust within the United States, holding substantial stakes in various energy-related assets. The trust maintains a 90% net profits interest across a selection of producing and nonproducing royalty and overriding royalty properties located in Texas, Oklahoma, and New Mexico. Additionally, it secures a 75% net profits working interest in seven specific properties, four of which are situated in Texas and three in Oklahoma. This entity was established in 1991 and its corporate headquarters are based in Dallas, Texas.
Positive results from the VOLGA Phase III trial showed perioperative treatment with AstraZeneca's IMFINZIÂ (durvalumab) in combination with neoadjuvant enfortu
Landmark results from the DeLLphi-305 Phase III trial showed IMFINZIÂ (durvalumab) plus Amgen's tarlatamab-dlle demonstrated a statistically significant and hi
Merck (NYSE: MRK), known as MSD outside of the United States and Canada, and Moderna, Inc. (NASDAQ: MRNA) today announced detailed positive recurrence-free surv
DALLAS, Oct. 20, 2026 /PRNewswire/ -- Argent Trust Company, as Trustee of the Cross Timbers Royalty Trust (the "Trust") (NYSE: CRT), today declared a cash distribution to the holders of its units of beneficial interest of $0.277908 per unit, payable on November 16, 2026, to unitholders of record on October 30, 2026. The following table shows underlying oil and gas sales and average prices attributable to the current month and prior month distributions.
[url="]Natera, Inc.[/url] (NASDAQ: NTRA), a global leader in cell-free DNA and precision medicine, today announced new data recently shared at the American Soci